Abstract

Substance use and substance use disorders among pregnant and postpartum individuals have risen dramatically, necessitating enhanced clinician education and intervention strategies. This expert review offers obstetricians and gynecologists a comprehensive overview of substance use during the prenatal and postpartum periods. We discuss the epidemiology, maternal and fetal adverse effects, as well as treatment approaches for major substances: nicotine, cannabis, alcohol, benzodiazepines, stimulants, and opioids. Additionally, we address the ethical and legal implications of substance use during pregnancy and emphasize the importance of equitable and nonstigmatizing care. By integrating evidence-based practices, we aim to support obstetricians and gynecologists in providing optimal care for pregnant and postpartum individuals affected by substance use disorders.

Original languageEnglish
Pages (from-to)337-353.e1
JournalAmerican Journal of Obstetrics and Gynecology
Volume232
Issue number4
DOIs
StatePublished - Apr 2025

Keywords

  • alcohol
  • benzodiazepines
  • cannabis
  • comprehensive overview of substance use
  • epidemiology
  • ethics
  • intervention
  • maternal and fetal adverse effects
  • nicotine
  • obstetric complications
  • opioids
  • postpartum substance disorders
  • substance use

Fingerprint

Dive into the research topics of 'Substance use and use disorders during pregnancy and the postpartum period'. Together they form a unique fingerprint.

Cite this